NCT02940132View on ClinicalTrials.gov

A Study of SC10914 in Patients With Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

May 31, 2018

Conditions
Advanced Solid Tumors
Interventions
DRUG

SC10914

SC10914 will be administered orally.

Trial Locations (1)

100142

RECRUITING

Beijing Cancer Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

INDUSTRY